NEW YORK , July 25, 2024 /PRNewswire/ -- The global bio-detection market size is estimated to grow by USD 16.84 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.
2% during the forecast period. Increasing incidence of infectious disease and cancer is driving market growth, with a trend towards increasing applications of microorganisms. However, inadequate healthcare services in developing regions poses a challenge.
Key market players include 20/20 GeneSystems Inc., 3M Co., Abbott Laboratories, AdVnt Biotechnologies LLC, Agilent Technologies Inc.
, Alexeter Technologies LLC, Bertin Technologies SAS, Bio Rad Laboratories Inc., Bruker Corp., Danaher Corp.
, F. Hoffmann La Roche Ltd., Illumina Inc.
, MBio Diagnostics Inc., Physical Sciences Inc., PositiveID Corp.
, Research International Inc., Response Biomedical Corp., Sense Biodetection Inc, Smiths Group Plc, and Thermo Fisher Scientific Inc.
. Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report Market Driver The bio-detection market is experiencing significant growth due to the increasing use of microorganisms in the production of various commercial products. Microorganisms are utilized in the production of food items and beverages, food additives and supplements, and microbial enzymes.
Industrial microbiologists carry out activities such as microorganism isolation, product screening, culture maintenance, and product re.